Juno Investor Seeks Records To Look Into $9B Celgene Deal
A shareholder of biopharmaceutical firm Juno Therapeutics Inc. filed a petition Friday in Delaware state court seeking inspection of the company's books and records so he can investigate the independence of...To view the full article, register now.
Already a subscriber? Click here to view full article